Arcutis Biotherapeutics ARQT
NASDAQ ARQT
$32.40 -0.42 (-1.28%)
As of: Oct 21, 2026 · 11:41 AM EDT

Arcutis Biotherapeutics (ARQT) Other financing activities (2019 - 2021)

Updated

Arcutis Biotherapeutics (ARQT) recorded Other financing activities of $2.19 million in FY2022, up 33.6% from $1.64 million in FY2021.

Analysis

Arcutis Biotherapeutics (ARQT) Other financing activities (2019 - 2021) Analysis & Trends

  • Per Business Quant data, ARQT's Other financing activities was $1.64 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn
10 Arcutis Biotherapeutics 4.24 Bn 3.53 Bn 118.92 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 -1.64 Mn
Dec 31, 2020 471,000.00
Dec 31, 2019 -1.29 Mn
API Access

Arcutis Biotherapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=ARQT&period=max&api_key=YOUR_API_KEY